U.S. Navy Preparing to Discharge Unvaccinated Sailors

Sailers saluting one another

On Thursday, the United States Navy announced its intentions to discharge any and all sailors who have not yet taken the coronavirus vaccine, according to Fox News.

The Navy’s press release on the matter declares that November 14th is the final deadline for sailors to receive the vaccine, while the deadline for reservists is December 14th. In addition to being discharged, sailors who refuse to get the vaccine may also lose some of their veterans’ benefits.

“Those separated only for vaccine removal,” the statement reads, “will receive no lower than a general discharge under honorable conditions. This type of discharge could result in the loss of some veterans’ benefits.” In addition, the statement said that the Navy “may also seek recoupment of applicable bonuses, special and incentive pays, and the cost of training and education for service members refusing the vaccine.”

Read More

Arizona Governor Issues Executive Order Preventing COVID Vaccine Mandates on College Campuses

Arizona Governor Doug Ducey announced on Tuesday an executive order that will prevent the state’s public colleges and universities from mandating the COVID-19 vaccine for its students.

The executive order comes in response to Arizona State University informing its students that they “expect” students to return to campus in the fall fully vaccinated. Further, individuals who choose not to receive the coronavirus vaccine would be subjected to a mask requirement and weekly testing.

Read More

Pfizer: Israeli Data Finds Vaccine Prevents 94 Percent of Asymptomatic Infections

Pfizer’s coronavirus vaccine was over 94% effective in preventing asymptomatic cases of COVID-19, according to real-world Israeli data released late Thursday.

The latest analysis suggests that Pfizer’s vaccine could overwhelmingly halt asymptomatic spread — a main driver of infections since asymptomatic people are often unaware they have the virus. The data also showed that the vaccine was 97% effective in preventing symptomatic cases, hospitalizations and deaths, slightly higher than the 95% effectiveness found in its clinical trials.

Read More

Trump Tells Supporters Who Don’t Want the Coronavirus Vaccine That It’s Safe and Effective

Former President Donald Trump urged Americans to get the coronavirus vaccine Tuesday evening, touting the treatments as safe and effective in fighting the virus.

“I would recommend it,” Trump said during a Fox News interview. “And I would recommend it to a lot of people who don’t want to get it and a lot of those people voted for me, frankly.”

Read More

Pfizer Vaccine Is Effective Against Fast-Spreading Brazilian Coronavirus Variant, Study Shows

Pfizer’s coronavirus vaccine was able to neutralize the highly transmissible Brazilian virus variant, a new lab study showed.

The effectiveness of the vaccine against the variant was “roughly equivalent” to the original strain, researchers told the New England Journal of Medicine. Its ability to combat the variant, known as P.1, is especially encouraging in Brazil, where it has spread throughout the country.

Read More

U.S. to Pay $4 Billion for Coronavirus Vaccine Distribution in Poor Countries

Joe Biden is set to announce today that the United States will be spending $4 billion on an effort to increase distribution of the coronavirus vaccine in poor and third-world countries, as reported by ABC.

Congress had approved spending the funds on an international vaccine distribution effort back in December; half of the money will go to an organization called Gavi, an international group that focuses specifically on vaccine distribution and is backed by the United Nations. The funding will cover Gavi’s operations throughout 2021 and 2022.

Read More

Safety Concerns Make a Third of Americans Hesitant to Receive the Coronavirus Vaccine, Poll Shows

Approximately a third of Americans say that they are unlikely to receive the coronavirus vaccine due to perceived safety concerns, according to an Associated Press poll released Wednesday.

While 67% of Americans said that they either planned to receive the vaccine or had already done so, 17% said that they were unlikely to receive it and 15% said that they were definitely not going to receive it, the poll showed. Among those who expressed vaccine hesitancy, the majority cited concerns over possible side effects and doubts over whether it was really safe, and nearly 40% said that they did not believe that they needed a vaccine.

Read More

Life Will Return to Normal in Seven Years, Vaccine Database Shows

It will take seven years for life to return to normal and for coronavirus to subside, a Bloomberg database tracking worldwide coronavirus vaccinations found.

Although countries like the U.S. and Israel have administered coronavirus at a rate that will ensure herd immunity by 2022, most countries have fallen behind that pace and will not catch up for seven years, according to Bloomberg. More than 119 million vaccines have been administered in 67 countries and the most recent rate of vaccination was 4.54 million doses per day, the vaccine database showed.

Read More